LG Chem Ltd. will spend at least $3 billion to build its first US cathode plant in Tennessee in response to the growing demand for electric vehicle (EV) components.
The cathode manufacturing facility will be capable of producing 120,000 tons a year by 2027, which would be enough to power 1.2 million pure EVs with a range of 500 kilometers per charge.
The construction will start in the first quarter of next year on a property stretching 1.7 million square meters. The plant will go into operation at the end of 2025.
According to LG Chem CEO Shin Hak-cheol, the cathode manufacturing facility brings them one step closer to becoming the world’s best battery materials manufacturer and fulfilling their corporate vision to become a top global science company.
The Inflation Reduction Act will require EV batteries to be made with higher portions of minerals processed or mined in the US, or countries with free trade pacts with the US.
LG Chem said it aims to boost its sales in the battery materials segment by fourfold to 20 trillion won by 2027 from 5 trillion won in 2022.


Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
Time to buy local: war fuel price shocks reveal the folly of a long food supply chain
Bank of Japan Unveils New Inflation Gauge to Support Case for Future Rate Hikes
Gold is meant to be a ‘safe haven’ in uncertain times. Why is it crashing amid a war?
SK Hynix Eyes Up to $14 Billion U.S. IPO to Fund AI Chip Expansion
Oil Prices Surge Past $100 as U.S.-Iran Peace Hopes Collapse
NASDAQ Tech Selloff: Correction or Collapse? What Analysts Are Saying
Gold Prices Drop Amid Iran Peace Talk Uncertainty and Stronger Dollar
Innate Pharma Reports 55% Revenue Drop and €49.2M Net Loss for 2025
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
NAB Plans to Cut 170 Jobs While Expanding Offshore Operations
Asian Currencies Hold Steady as Dollar Stays Firm Amid Middle East Uncertainty
Rise of the Zombie Bugs takes readers on a jaw-dropping tour of the parasite world
Reflection AI Eyes $25 Billion Valuation in Massive $2.5 Billion Funding Round
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
OpenAI Pulls the Plug on Sora, Ending $1 Billion Disney Partnership 



